Muhlenkamp & Co. Inc. purchased a new position in shares of Royal Gold, Inc. (NASDAQ:RGLD – Free Report) (TSE:RGL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 56,859 shares of the basic materials company’s stock, valued at approximately $6,526,000. Royal Gold […]
Muhlenkamp & Co. Inc. acquired a new position in Franco-Nevada Co. (NYSE:FNV – Free Report) (TSE:FNV) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 47,783 shares of the basic materials company’s stock, valued at approximately $6,814,000. Franco-Nevada accounts for 2.4% of Muhlenkamp & […]
Muhlenkamp & Co. Inc. acquired a new stake in Schlumberger Limited (NYSE:SLB – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 311,735 shares of the oil and gas company’s stock, valued at approximately $15,312,000. Schlumberger makes up approximately 5.4% of […]
Muhlenkamp & Co. Inc. bought a new position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 129,569 shares of the biopharmaceutical company’s stock, valued at approximately $8,286,000. Bristol-Myers Squibb accounts for about 2.9% of Muhlenkamp […]
Muhlenkamp & Co. Inc. bought a new stake in shares of Alerian MLP ETF (NYSEARCA:AMLP – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 174,555 shares of the exchange traded fund’s stock, valued at approximately $6,844,000. […]